This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements.
Nature communications · 2019
Latest funding
- $2,550,000
Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries
CIHR · 2019 · Principal investigator
- $1,769,650
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
CIHR · 2017 · Principal investigator
- $753,035
New statistical methods for cohort studies of adverse effects of medications
CIHR · 2016 · Co-investigator
1 publications.
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements.
Allum F, Hedman ÅK, Shao X, Cheung WA, Vijay J, Guénard F, Kwan T, Simon MM, Ge B, Moura C, Boulier E, Rönnblom L, Bernatsky S, Lathrop M, McCarthy MI, Deloukas P, Tchernof A, Pastinen T, Vohl MC, Grundberg E
Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries
Principal investigators: Bernatsky, Sasha R; Abrahamowicz, Michal M; Afif, Waqqas; Awadalla, Philip; Bérard, Anick; Buckeridge, David L; Hazlewood, Glen S; Hohl, Corinne M; Kowalec, Kaarina A; Moride, Yola; Moura, Cristiano S; Pilote, Louise; Tremlett, Helen L
Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modelling
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
Principal investigators: Bernatsky, Sasha R; Boire, Gilles; Bykerk, Vivian P; Lakatos, Peter; Maksymowych, Walter P; Moura, Cristiano S; Targownik, Laura E
Keywords: Des
New statistical methods for cohort studies of adverse effects of medications
Principal investigators: Abrahamowicz, Michal M
Keywords: Biostatistics; Comparative Effectiveness; Competing Risks; Confounding Bias; Cumulative Effects; Exposure Measurement Errors; Pharmacoepidemiology; Simulations; Statistical Modeling; Time-Varying Exposure
Canadian Network for Advanced Interdisciplinary Methods for Prospective Studies of Drug Safety and Effectiveness
Principal investigators: Abrahamowicz, Michal M; Bérard, Anick; Bernatsky, Sasha R; Hohl, Corinne M; Lacaille, Diane V; Levesque, Linda E; Levy, Adrian R; Moride, Yola; Pilote, Louise
Keywords: Comparative Effectiveness And Safety; Confounding Bias; Exposure Measurement Errors; Pharmacoepidemiology; Prospective Studies; Statistical Modeling
Post Market Drug Safety and Effectiveness: Ankylosing Spondylitis
Principal investigators: Bernatsky, Sasha R; Rahme, Elham
Keywords: Ankylosing Spondylitis; Arthritis; Disease-Modifying Anti-Rheumatic Drugs; Dmards; Drug Effectiveness; Drug Safety
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Nutrition
- Medicine
- Human Genetics
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.